IPrEx
id:
iprex-197-15218397
title:
IPrEx
text:
iPrEx was a phase III clinical trial to determine whether the antiretroviral medication emtricitabine/tenofovir could safely and effectively prevent HIV acquisition through sex in men who have sex with men and transgender women. iPrEx was the first human study of an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. The study began in 2007 at four study sites in Peru and Ecuador, following three years of extensive community and stakeholder consultation. In 2008 the study expande
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/IPrEx
date created:
date modified:
2022-06-30T01:17:34Z
main entity:
{"identifier":"Q5973253","url":"https://www.wikidata.org/entity/Q5973253"}
image:
fields total:
13
integrity:
13